Razzouk C, Mercier M, Roberfroid M
Cancer Lett. 1980 Apr;9(2):123-31. doi: 10.1016/0304-3835(80)90116-0.
Many reports in the literature have indicated that the guinea-pig is resistant to the carcinogenic effect of N-2-fluorenylacetamide (2FAA); this refractoriness has been attributed to its lack of N-hydroxylating enzymes. The present communication, however, supports the results of contradictory reports which demonstrate that guinea-pig liver microsomes are in fact able to N-hydroxylate both 2-fluorenamine and 2FAA. The guinea-pig N-hydroxylase activity toward 2-fluorenamine is found to be even greater than the reported activity in the rat and hamster. It is similarly inhibited by 3-methylcholanthrene (3MC), 7,8-benzoflavone (7,8 BF) or miconazole. Activity toward N-2-fluorenacetamide is present in the microsomal preparation from the control guinea-pig. There is slight activation by SKF525A, paraoxon (PX) or sodium fluoride. Under optimum conditions, in the presence of both paraoxon and sodium fluoride, activity is equivalent to that of rat liver microsomal enzymes.
文献中的许多报告表明,豚鼠对N - 2 - 芴基乙酰胺(2FAA)的致癌作用具有抗性;这种难治性归因于其缺乏N - 羟化酶。然而,本通讯支持了相互矛盾的报告结果,这些结果表明豚鼠肝微粒体实际上能够对2 - 芴胺和2FAA进行N - 羟化。发现豚鼠对2 - 芴胺的N - 羟化酶活性甚至高于报道的大鼠和仓鼠的活性。它同样受到3 - 甲基胆蒽(3MC)、7,8 - 苯并黄酮(7,8 BF)或咪康唑的抑制。对照豚鼠的微粒体制剂中存在对N - 2 - 芴乙酰胺的活性。SKF525A、对氧磷(PX)或氟化钠有轻微激活作用。在最佳条件下,在对氧磷和氟化钠同时存在的情况下,活性与大鼠肝微粒体酶相当。